Evaluation of the prevalence and caracterization of rinosinusitis in primary health care centers in Portugal
DOI:
https://doi.org/10.34631/sporl.128Keywords:
Rinossinusite, prevalência, diagnóstico, tratamentoAbstract
Objective: To determine RS prevalence, diagnosed at the Portuguese Primary Health Care Centres (PHCC), and to assess diagnostic and treatment practices.
Study Design: Epidemiologic, cross-sectional study.
Material and Methods: A cohort of subjects attending general practice medical appointments, in selected PHCC, was evaluated.
Results: Between May/2008 and June/2009, 1,201 subjects were included with a mean age of 41.7±13.2 years, of which 71% were female. The total prevalence of RS was 19.2%, [n=231; 17.1%, 21.5%; 95% CI]. The prevalence of acute RS was 7.4%, [n=89; 6.0%; 9.0%; 95% CI], and of chronic RS was 13.0% [n=156; 11.2%, 15.0%; IC 95%]. The estimated prevalence of RS is high. About 92% of patients with RS presented at least one symptom for disease diagnosis (p<0.001).
Conclusions: Half of the patients (50%) with RS had already been submitted to, at least, one medical exam. Same relevant difference between RS diagnostic and treatment guidelines and the current practice in Primary Health Care Centres were found.
References
Lopes G. Patologia infecciosa ORL na comunidade: perguntas frequentes. Rev Port Clin Geral 2005;21:401-15.
Mullol J, Valero A, Alobid I. The nose – from symptoms to evidence-based medicine. Allergy 2007;62:339-343.
Rosenfeld RM, Andes D, Bhattacharyya N, Cheung D, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007;137:S1-S31.
Bhattacharyya N. Chronic rhinossinusitis: is the nose really involved? Am J Rhinol 2001;131(Suppl):S1-S62.
Fokkens W, Lund V, Bachert C, Clement P, et al. European position paper on rhinosinusitis and nasal polyps. Rhinology 2005;44(Suppl):1-88.
Fokkens W, Lund V, Mullol J, On behalf of the European position paper on rhinosinusitis and nasal polyps group. Rhinology 2007;45(Suppl 20):1-139.
Van Gageldonk-Lafeber AB, Heijnen ML, Bartelds AI, Peters MF, et al. A case-control study of acute respiratory tract infection in general practice patients in The Netherlands. Clin Infect Dis 2005 Aug 15;41(4):490-7.
Van Cauwenberge P, Watelet JB. Epidemiology of chronic rhinosinusitis. Thorax 2000;55:S20-21.
Lund V. Therapeutic targets in rhinossinusitis: infection or inflammation? Medscape J Med 2008;10(4):105.
Barros E, Monteiro L, Prata JB, Vieira AS, et al. Avaliação da prevalência e caracterização da rinossinusite em Portugal – estudo epidemiológico. Revista Portuguesa de Otorrinolaringologia e Cirurgia Cérvico-Facial 2008;46(4):243-50.
National Center for Health Statistics. Health, United States, 2005: With Chartbook on Trends in the Health of Americans. Hyattsville, Md: National Center for Health Statistics; 2005.
Jones NS, Smith PA, Carney AS, Davis A. The prevalence of allergis rhinitis and nasal symptoms in Notthingham. Clin Otolaryngol Allied Sci 1998; 236:547-54.
Meltzer EO, Szwarcberg J, Pill MW. Allergic rhinitis, asthma, and rhinosinusitis: diseases of the integrated airway. JMCP 2004;10(4):310-17.
Dixon AE. Rhinosinusitis and asthma: the missing link. Curr Opin Pulm Med. 2009 Jan;15(1):19-24.
Jani AL, Hamilos DL. Current thinking on the relationship between rhinosinusitis and asthma. J Asthma. 2005 Feb;42(1):1-7.
Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005;116(6):1289-95.
Ryan D. Management of acute rhinosinusitis in primary care: changing paradigms and the emerging role of intranasal corticosteroids. Primary Care Respiratory Journal 2008;17(3):148-55.
